Ashland Inc. (ASH) as of March 31, 2026 presents a deeply negative liquidation posture, consistent with prior quarters. MFFAIS CLV of -$1.51B and OLV of -$761M confirm the pattern. The asset base is dominated by intangibles and goodwill, which receive zero recovery under liquidation mechanics. Total assets of $4.50B include goodwill of $700M and net intangibles of $529M (gross $1.64B less accumulated amortization of $1.11B) — combined $1.23B that evaporates in liquidation. PP&E gross of $3.36B less accumulated depreciation of $2.20B yields net book value of $1.16B; at a 50-70% recovery haircut, realized value is approximately $580M-$810M. Inventory of $506M at 60% yields ~$304M. AR of $244M (net of $4M allowance) at 90-95% yields ~$220M-$232M. Cash of $343M recovers at par. Restricted investments (current $50M, noncurrent $276M totaling $326M) are earmarked for asbestos ($213M) and environmental ($113M) trust obligations and are not available to general creditors, so these offset directly against the corresponding liabilities and should be treated as encumbered. On the liability side, long-term debt at face value is $1.374B (principal $1.405B less discounts). Pension noncurrent is $96M. Environmental accrual total is $219M on-balance-sheet plus $480M reasonably possible additional loss per disclosure, with $171M noncurrent booked. Asbestos litigation reserve (LitigationReserveNoncurrent) is $362M. Operating lease liabilities are $104M current and noncurrent combined. OtherLiabilitiesNoncurrent of $290M includes deferred comp and other legacy items. Total current liabilities $395M, noncurrent liabilities $2.24B — total liabilities approximately $2.63B. Against liquidated asset value well below book, recovery to equity is negative. Key change vs. prior filing (Q1 FY2026, period ended December 31, 2025): cash improved materially from ~$215M to $343M (+$128M), driven by $103M tax refund (Nutraceutical capital loss carryback) and favorable working capital; long-term debt declined modestly from $1.387B to $1.374B. Both S&P and Moody's downgraded to sub-investment grade (BB/Ba2) during the six-month period. Full-year Adjusted EBITDA guidance was cut to $385-400M from $400-420M, reflecting Hopewell HEC manufacturing ramp failures and $10-12M of reduced savings. Environmental expense for the six-month period was $12M vs. $3M in the prior-year period, and the environmental accrual saw a $11M downward revision in estimates during the period. Asbestos and environmental restricted investments declined from $347M to $326M as claims were paid. The filing discusses asbestos reserve amounts and the $480M reasonably possible additional environmental exposure in MD&A/footnotes but the specific asbestos liability balance is tagged only as LitigationReserveNoncurrent in XBRL.
▼ Community Notes